Clinical Results of Retatrutide: What Global Trials Reveal About Its Effectiveness
Retatrutide is emerging as one of the most closely watched investigational drugs in obesity and metabolic medicine. Designed as a triple agonist targeting GLP-1, GIP, and glucagon receptors, it represents a significant departure from earlier weight-loss therapies that focused on appetite suppression alone. For clinicians, patients, and health systems, global clinical trial data provide the…
